-+ 0.00%
-+ 0.00%
-+ 0.00%

JMP Securities Reiterates Market Outperform on CureVac, Maintains $16 Price Target

Benzinga·02/14/2025 15:07:55
Listen to the news
JMP Securities analyst Roy Buchanan reiterates CureVac (NASDAQ:CVAC) with a Market Outperform and maintains $16 price target.